Histological Pattern Of Ovarian Neoplasms And Their Age Wise Distribution-Study Conducted At A Tertiary Care Hospital by Iftikhar, Fazeelat et al.
Journal of Rawalpindi Medical College; 2018;22(S-2): 73-76 
 73 
Original Article 
 
 
  Histological Pattern Of Ovarian Neoplasms And Their Age 
Wise Distribution-Study Conducted At A Tertiary Care 
Hospital 
 
Fazeelat Iftikhar1, Hira Anum1, Naghmana Iftikhar2, Ammara Ijaz3, Naima Gul1 
1 4th year MBBS RMU 
2 Final Year MBBS RMU 
3 Department of Pathology Benazir Bhutto Hospital, Rawalpindi 
 
Abstract 
Background: Ovarian cancer is the 6th most 
common cancer in females in USA. The purpose of 
this study is to determine the distribution of 
histopathological types of ovarian cancers in 
different age groups of females to provide an 
institutional experience. 
Methods: This descriptive cross-sectional study 
included 123 cases of ovarian neoplasms reported 
from January 2014 to June 2017 in Benazir Bhutto 
Teaching Hospital, Rawalpindi, Pakistan. The 
patients who underwent surgery for ovariotomy 
alone or along with hysterectomy were selected in 
the study. All the patients with proved 
histopathological diagnosis of ovarian tumors were 
included in the study, while all those with other 
ovarian pathologies were excluded. Non probability 
consecutive sampling technique was used. The 
WHO classification of ovarian tumors was the basis 
of histopathological reports (HPR).  
Results: The results ascertained that 107(86.99%) 
tumors were benign while 16 (13.01%) were 
malignant. 82.3% were surface epithelial tumors and 
17.7% were germ cell tumors. Serous cystadenoma 
was the most common benign tumor being 54.2% of 
all tumors while serous adenocarcinoma was the 
most common malignant tumor (62.5%). Most of 
tumors were seen in reproductive age group. Benign 
tumors were more common below 40 years of age 
while malignant neoplasms were more common 
above 40 years. Only 4 tumors were bilateral. 
Conclusion: Benign ovarian neoplasms are 
commonest of ovarian tumors. These are common in 
age group <40 years. 
Key words: Germ cell tumor, ovarian tumors, 
ovary. 
 
 
Introduction 
Ovarian cancer is 6th most common cancer in females 
in USA.1 Ovarian tumors are one of the major causes 
of gynecological problems in females and present with 
marked variation in their histological types. Relative 
frequency of these lesions is different for Western and 
Asian countries.2 The WHO histological classification 
of ovarian tumors separates ovarian neoplasms 
according to most probable tissue of origin; surface 
epithelial tumors (65%), germ cell (15%), sex cord –
stromal (10%), metastatic 5%. Surface epithelial tumors 
are further classified by cell types (into serous, 
mucinous, endometroid etc) and atypia (benign, 
borderline, and malignant). Most malignant tumors 
are surface epithelial tumors.3 Ovarian cancer has 
often been called the “silent killer” because of 
nonspecific symptoms and a lack of trustworthy 
screening for its early detection. Majority of cases are 
diagnosed late when they are in an advanced stage or 
large enough in size. It contributes not only to 
diagnostic delay and a poor prognosis but is also 
responsible for the increased burden of the diseases.4 
The risk of a female newborn to have ovarian tumor 
during her lifetime is 6.0-7.0%, of having ovarian 
cancer is almost 1.5% and dying from ovarian cancer is 
1.0%.5 Peak incidence of ovarian tumor is between 21-
40years.6,7 Benign ovarian tumors occur in all age 
group whereas malignant ovarian tumors are more 
common in the elderly.7  Majority of benign serous 
tumors occur in 4th–6th decade although they may 
occur in patients younger than 20 or older than 80 
years.3 Serous carcinomas are extremely rare in first 
two decades of life, average patient age for serous 
carcinomas is 56 years. Mucinous cystadenoma may 
occur at any age but are most often diagnosed in 4th–
6th decade. Mucinous cancers have a mean age of 53-
54 years.5 According to research conducted at Armed 
Force Institute of Pathology, Rawalpindi Pakistan in 
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2015, the most common tumors in adolescents and 
adults (21-30 years) are surface epithelial tumors 
constituting 365 cases (17%) of all ovarian tumors, 
followed by germ cell tumors constituting 246 cases 
(11.5%). Commonest tumors in middle age and older 
age group are surface epithelial tumors.4 
This study was conducted with the aim to find out 
frequency of different histological types of ovarian 
tumors reported from Department of Pathology at 
Benazir Bhutto Hospital Rawalpindi, Pakistan and to 
analyze age distribution of these tumors. 
 
Materials and method 
This was a descriptive cross-sectional study and 
included 123 cases of ovarian neoplasms reported 
from January 2014 to June 2017 in Benazir Bhutto 
Teaching Hospital Rawalpindi, Pakistan. Approval 
was taken from institutional research forum and 
ethical review committee of RMC and from the 
authority of Histopathology department of Benazir 
Bhutto Hospital. Non probability consecutive 
sampling technique was used.  
Patients who underwent surgery for ovariotomy alone 
or along with hysterectomy were selected in the study. 
Histopathological examination of the specimens was 
conducted by the department of Histopathology 
following appropriate staining (haematoxylin and 
eosin staining). All the patients with proved 
histopathological diagnosis of ovarian tumors were 
included in the study. The other ovarian diseases 
including inflammation and abscesses were not 
included. A total of 123 cases fulfilled the inclusion 
criteria. We reviewed histopathology report of the 
cases in the study. Histopathological diagnosis, tumor 
type, tumor subtype, laterality and age of patients 
were noted. All the required data was retrieved from 
records of histopathology department of BBH. The 
WHO classification of ovarian tumors was the basis of 
Histopathological Reports (HPR). Data was entered in 
IBM SPSS version 23 and descriptive statistics were 
applied. 
 
Results 
Out of 123 ovarian tumors 107 (86.99%) were benign 
while 16 (13.01%) were malignant. Surface epithelial 
tumors 102(82.9%) were the most common followed by 
germ cell tumors 21 (17.1%).There were no sex cord-
stromal and metastatic tumors reported during our 
study period. Surface epithelial tumors comprised 86 
(80.4%) of all benign neoplasms whereas all malignant 
neoplasms were surface epithelial in nature. Germ cell 
tumors comprised 21(19.6%) of benign ovarian 
neoplasms. Most common benign ovarian tumor was 
serous cyst adenoma 58 (54.2%) followed by mucinous 
cyst adenoma 28 (26.2%). Mature cystic teratoma 
constitutes 21 (19.6%) of all benign tumors. Serous cyst 
adenocarcinoma was most common (62.5%) of all 
malignant tumors followed by mucinous cyst 
adenocarcinoma (37.5%). Benign ovarian neoplasms 
were common in all age groups below 60 years of age 
while malignant were more common in elderly ages. 
Of all benign tumors, 89 (83.17%) were found in up to 
40 years of age whereas only 18 (16.83%) of total 
benign tumors were found in patients above 40 years 
of age (Table I). Malignant tumors were far less 
common below 40 years. Out of all malignant tumors, 
13 (81.25%) were seen above 40 years where as this 
figure was 3 (18.75%) among patients up to 40 years 
(Table II). Tumors belonging to borderline category 
were not seen during our study period. 
Bilaterality was more a feature of benign tumors as all 
4 bilateral ovarian tumor in our study were benign in 
nature where as all 16 malignant tumors were 
unilateral. 
 
Table I: Frequency of individual Benign tumors in 
different age group 
Diagnosis  Up to 
20 year 
21-40 
years 
41-60 
years 
Above 
60 years 
Total 
Mature cystic 
teratoma 
8 11 2 0 21 
Serous cyst 
adenoma 
6 42 10 0 58 
Mucinous cyst 
adenoma 
1 21 6 0 28 
Theoma 0 0 0 0 0 
Fibroma 0 0 0 0 0 
Serous cyst 
adenofibroma 
0 0 0 0 0 
Total 15 74 18 0 107 
 
Table lI: Frequency of individual Malignant tumors 
in different age group 
Diagnosis Up to 
20 
years 
21-40 
years 
41-60 
years 
Above 
60 
years 
Total 
Serous cyst 
adenocarcinoma 
0 2 3 5 10 
Mucinous 
cystadenocarcinoma 
0 0 5 1 6 
Metastatic 
adeno/Krukenburg 
0 0 0 0 0 
Immature teratoma 0 0 0 0 0 
Granulosa cell tumor 0 0 0 0 0 
Yolk sac 0 0 0 0 0 
Total 0 2 8 6 16 
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Figure 1: Adenexal Mass 
 
 
Figure 2: High Grade Serous Carcinoma Of Ovary 
 
 
Figure 3: Serous Cystadenoma Of Ovary 
 
 
Figure 4: Mucinous Cystadenoma Of Ovary 
 
Discussion 
A number of neoplastic and non-neoplastic lesions can 
occur in ovaries. Ovarian masses are very common. 
They range from benign cysts to highly aggressive 
malignant tumors.4 Diagnosis of ovarian tumors can be 
difficult due to a variety of pathologic conditions that 
can affect the ovaries and present with similar clinical 
and radiological manifestations. The histopathological 
pattern of ovarian tumors is important upon which 
further management rests. 
In this study 86.99% tumors were benign and 13.01% 
were malignant. This is similar to a study conducted in 
Nepal in 2009 where 90% were benign and 10% were 
malignant.8 On studying data collected from Western 
countries it was found out that 75% to 80% ovarian 
tumors were benign.5 Also, a study carried out in India 
by Pilli et al had approximately similar results which 
showed that 75.2% ovarian tumors were benign.6 
However, this figure was only 59.2% in a study carried 
in Pakistan by Ahmed et al.9 
In our study, surface epithelial tumors comprised 
82.3% of all ovarian tumors. All malignant tumors in 
our study were surface epithelial in nature whereas in 
another study carried in Pakistan, this was found to be 
63.5%.9 The results from similar studies conducted in 
neighboring countries like India and Nepal were 
67.9% and 52.2% respectively.6, 1 Surface epithelial 
tumors accounted for 46-50% of all ovarian tumors in 
Japan.5 
In this study, serous tumors accounted for 55.28% of 
all ovarian neoplasms, 85.3% of them were benign and 
14.7% were malignant. In West, serous tumors 
accounted for 30% of all ovarian neoplasms and 60% 
of these were benign, 10% were borderline and 30% 
were malignant.5  In another study carried out in 
Pakistan, benign serous tumors comprised 64.5% and 
their malignant counterpart were 35.5% of all tumors.10 
In our study, mucinous tumors accounted  for 27.6% of 
all ovarian tumors which resemble another study 
carried out in India in which this figure was 25.5%.6 In 
another study conducted in Nepal this figure was 
16.8%.1 Out of all mucinous tumors 82.4% were benign 
and 17.6%  were malignant . 
In other studies serous cystadenoma was the 
commonest benign tumor similar to our study whereas 
 it was mature cystic teratoma in studies which were 
conducted in Nepal and USA .9-12 Serous 
cystadenocarcinoma was the commonest malignant 
tumor in this study which is consistent with other 
studies.1,9,11,12 
Germ cell tumors were second major group of tumors 
in the present study and comprised 17.1% of all 
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ovarian neoplasms. In other studies this figure was 
23.1%and 23.9% respectively.10,13 Sex cord stromal 
tumors were not present in our study whereas in 
another study carried in Pakistan,11 this tumor 
comprised 3.15% and in West it comprised 5% of the 
total.14  Malignant germ cell tumors are the most 
common ovarian cancers among children and 
adolescent females.2 Germ cell ovarian tumor is one of 
the major ovarian neoplasms in the first two decades 
of life. In this study mature cystic teratoma accounted 
for approximately half of ovarian neoplasms that 
appeared in the 1st two decades of life. Immature 
teratoma was not seen in our study.  In our study, in 
patients under the age of 21, approximately 53.3% 
ovarian tumors were germ cell tumors. 
Ovarian neoplasms can occur in all age groups and no 
age is exempted. Our study showed that most ovarian 
tumors occur in women of reproductive age group. 
Benign ovarian tumors occurred in all age groups 
whereas malignant ovarian tumors were more 
common in elderly age group. Majority of benign 
serous tumors occurred in 2nd-6th decades of life 
although they may occur in patients younger than 20 
years or older than 80 years.3 Serous carcinoma was 
not seen in first two decade of life in our study.  
Ovarian tumors are well known for bilateral 
involvement. The likelihood of bilateral involvement 
by primary ovarian tumors varies with histologic 
subtype. In this study, 4 ovarian tumors were bilateral. 
All these bilateral tumors were benign in nature 
whereas all 16 malignant tumors in our study were 
unilateral. In similar studies conducted in neighboring 
countries like Nepal and India bilaterality was more a 
feature of malignant neoplasm.1,10 
Ovarian cancer is the third most common malignancy 
in Karachi (after breast and oral cancer) with an age 
standardized incidence rate of 10.9%.15 In this study, 
some data approximated to data from the western 
world whereas some approximated to that of 
neighboring countries like India and Nepal. Even 
results of two studies within Pakistan are different 
from each other.2,4,11 Whether this represents changing 
trend in this region of the world or not needs to be 
uncovered by further studies.16 This study as well as 
most of the studies from India and Nepal which are 
included here for comparison had small sample sizes 
whereas in the Western world, large population based 
studies were done. This could be one cause of 
variation in results. The difference from other studies 
may be due to sample size but genetic, socioeconomic 
and environmental factors may also be involved. 
This study is institution based and has a small sample 
size so; the results obtained may or may not reflect the 
actual histological pattern and age distribution of 
ovarian tumors in Pakistani women. Therefore, more 
studies with larger sample sizes need to be conducted. 
Conclusion 
Knowing specific histology of ovarian mass is 
becoming increasingly important as management 
options have become more tailored to individual 
patients. Benign ovarian tumors are common in our 
setup. Most of ovarian neoplasms are noted in 
reproductive age group. The risk of malignancy 
increases with increasing age. 
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